Clinical trial No longer in our active list Observational Ages 18 and up

Database of stroke patients treated with thrombectomy

Official title: REperfusion Therapy for Acute Ischemic STrOke Due to Large aRtEry Occlusion

Run by Beijing Tiantan Hospital · NCT05311605 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is creating a database to help understand how well a procedure called thrombectomy works for stroke patients and what factors might affect its success.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1600 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing)
Trial IDNCT05311605 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 years with confirmed large vessel occlusion and who have undergone necessary imaging within the specified time frame.

Probably not a fit

Patients with a history of certain medical conditions or those unable to undergo imaging or receive contrast agents may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a clinical and advanced imaging database for acute ischemic stroke patients who have undergone mechanical thrombectomy due to large vessel occlusion in the anterior circulation within 24 hours of stroke onset. It will involve a multi-center, prospective registry cohort study across various stroke centers in China, enrolling approximately 1600 patients. The study will also analyze predictors and mechanisms of futile recanalization after the procedure, utilizing both prospective and retrospective data.

Why it matters

Potential benefit: If successful, this study could improve understanding of treatment outcomes and optimize mechanical thrombectomy protocols for stroke patients.

How similar studies have gone: Previous studies like DAWN and DEFUSE 3 have shown success in extending the time window for mechanical thrombectomy, but this study aims to provide real-world evidence within that timeframe.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Older than 18 years;
* Perfusion imaging completed including CTA+CTP or MRA+PWI+DWI before thrombectomy
* Large vessel occlusion of cerebral anterior circulation (ICA, MCA-M1 or MCA-M2) confirmed by CTA or MRA, planned to receive or received stenting or aspiration thrombectomy
* Time intervals ≤ 24 hours from stroke onset to groin puncture.(fulfilled the inclusion of DAWN or DEFUSE 3 trial if the time intervals from stroke onset to groin puncture was ≥6 hours)
* mRS score ≤2 before admission
* Informed consent obtained for longitudinal enrolled patients, waived of consent for retrospectively included cases

Exclusion Criteria:

* Had a history of infective disease, immunity disease, radiotherapy at head or neck, carotid dissection or other carotid disease.
* Unable to receive CT or MR scan due to heart failure, cardiac pacemaker, metal implants or claustrophobia, etc.
* Unable to be injected with contrast agent due to allergy, renal dysfunction, etc.
* Unlikely to adhere to the study protocol or follow-up ( life expectancy ≤ 3 months)
* Already participated in other drug trials

Where it's running

  • Yunyun Xiong
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.